Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mosapride sustained release plus esomeprazole vs esomeprazole monotherapy in gastroesophageal reflux disease
KCT0004062Phase 4Completed
- Sponsor
- Daewoong Pharmaceutical
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of mosapride, esomeprazole in gastroesophageal reflux disease (GERD), sponsored by Daewoong Pharmaceutical. Started Jul 2019; status: completed.
02
Drugs
mosaprideesomeprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on KCT0004062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0004062.